Mirador Therapeutics

A new vantage point on inflammation and fibrosis

San Diego, United States · Founded 2024 · $650.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$650.0M
Last Round
$250.0M Series BOct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mirador Therapeutics is a clinical-stage precision medicine company developing targeted therapies for immune-mediated inflammatory and fibrotic diseases. Using Mirador360™, an integrated platform with multi-modal data, AI, and advanced analytics, it identifies novel targets and optimal therapies to accelerate pipeline development.

Summary

Mirador Therapeutics is a Biotech company based in San Diego, United States, founded in 2024. It has raised $650.0M in total across 2 rounds, most recently a $250.0M Series B round in Oct 2025. Investors include ARCH Venture Partners, OrbiMed and Innovation Endeavors.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2025
$250.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mirador Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mirador-therapeutics"><img src="https://indexed.vc/api/badge/company/mirador-therapeutics" alt="Mirador Therapeutics on Indexed.vc" width="260" height="76" /></a>